Skip to main content

Advertisement

SpringerLink
Log in

Liuwei Dihuang Pill (六味地黄丸) Treats Postmenopausal Osteoporosis with Shen (Kidney) Yin Deficiency via Janus Kinase/Signal Transducer and Activator of Transcription Signal Pathway by Up-regulating Cardiotrophin-Like Cytokine Factor 1 Expression

  • Original Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objectives

To investigate the mechanism of Liuwei Dihuang Pill (六味地黄丸, LDP) in treating postmenopausal osteoporosis (PMOP) with Shen (Kidney) yin deficiency.

Methods

In this study, 205 cases of PMOP were divided into the PMOP Shen-yin deficiency group (Group A), PMOP Shen-yang deficiency group (Group B), PMOP without Shen deficiency group (Group C), and control group (Group N). Real-time polymerase chain reaction (RT-PCR) and Western blot techniques were used to observe the effects of LDP treatment on the cardiotrophin-like cytokine factor 1 (CLCF1), ankyrin repeat and SOCS box containing 1 (ASB1), and prokineticin 2 (PROK2) genes and the Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathway.

Results

The mRNA (P<0.05) and protein (P<0.01) expression levels of the CLCF1 gene in Group A were significantly lower than the corresponding levels in Group N. After LDP treatment for 3 months, the mRNA expression levels of the CLCF1 gene were obviously up-regulated (P<0.01). After 6-month treatment, the expression levels of CLCF1 mRNA and protein were significantly up-regulated (both P<0.01), and the average bone density of the top femur had significantly increased (P<0.05). In vitro, CLCF1 overexpression resulted in a significant increase in the total protein and phosphorylated protein levels of JAK2 and STAT3.

Conclusions

The CLCF1 gene is an important gene associated with PMOP Shen-yin deficiency and the therapeutic effects of LDP may be mediated by up-regulation of CLCF1 gene expression and activation of the JAK/STAT signaling pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Scott LJ. Denosumab: a review of its use in postmenopausal women with osteoporosis. Drugs Aging 2014;31:555–576.

    Article  PubMed  CAS  Google Scholar 

  2. Li DT, Li FY, Wang J, Liu JH, Yan N, Cheng YM, et al. A study of diagnostic criteria for traditional Chinese medicine syndromes in osteoporosis. J Chin Integr Med (Chin) 2011;9:1326–1332.

    Article  Google Scholar 

  3. Xia BJ, Tong PJ, Sun Y, Zhou LY, Jin HT. Methods and evaluations on the sterioid-induced osteoporosis mice model with the type of Kidney-yin deficiency. China J Orthop Traumatol (Chin) 2014;27:673–679.

    CAS  Google Scholar 

  4. Xie LH, Zhao YP, Chen K, et al. Bioinformatics analysis of genes expression profiles of postmenopausal osteoporosis with Kidney yin deficiency. J Clin Rehab Tissue Engin Res (Chin) 2011;15:2833–2837.

    CAS  Google Scholar 

  5. Tarca AL, Bhatti G, Romero R. A comparison of gene set analysis methods in terms of sensitivity, prioritization and specificity. PLoS One 2013;8:e79217.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Chamorro CI, Zeiai S, Engberg GR, Brodin D, Nordenskjöld A, Fossum M. A study on proliferation and gene expression in normal human urothelial cells in culture. Tissue Eng Patr A 2015;21:510–517.

    Article  CAS  Google Scholar 

  7. Xie YM, Yuwen Y, Dong FH, Sun SC, Wang HM, Liu QS, et al. Clinical practice guideline of traditional medicine for primary osteoporosis. Chin J Integr Med 2011;17:52–63.

    Article  PubMed  Google Scholar 

  8. Jiang M, Lu C, Zhang C, Yang J, Tan Y, Lu A, et al. Syndrome differentiation in modern research of traditional Chinese medicine. J Ethnopharmacol 2012;140:634–642.

    Article  PubMed  Google Scholar 

  9. Peacock M, Turner CH, Econs MJ, Foroud T. Genetics of osteoporosis. Endoc Rev 2002;23:303–326.

    Article  CAS  Google Scholar 

  10. Sugiya N, Nakashima A, Takasugi N, Kawai A, Kiribayashi K, Tanaka J, et al, Endogenous estrogen may prevent bone loss in postmenopausal hemodialysis patients throughout life. Osteoporos Int 2011;22:1573–1579.

    Article  PubMed  CAS  Google Scholar 

  11. Nakashima T, Takayanagi H. Osteoimmunology: crosstalk between the immune and bone systems. J Clin Immunol 2009;29:555–567.

    Article  PubMed  Google Scholar 

  12. Liu ZH, ed. Osteoporosis research and prevention. Beijing: Chemical Industry Press; 1994:226–261.

  13. Xia B, Xu B, Sun Y, Xiao L, Pan J, Jin H, et al. The effects of Liuwei Dihuang on canonical Wnt/β-catenin signaling pathway in osteoporosis. J Ethnopharmacol 2014;153:133–141.

    Article  PubMed  Google Scholar 

  14. Zhou P, Zhou Q. Observation of the Liuwei Dihuang Pill treatment of 30 cases of osteoporosis in older men. Shanxi J Tradit Chin Med (Chin) 2014;35:1191–1192.

    CAS  Google Scholar 

  15. Zhang HB, Li CY. Effect of Liuwei Dihuang Pill on bone mineral density of the primary osteoporosis (Shen yin deficiency). Chin J Tradit Med Traumatol Orthop (Chin) 2011;19:18–20.

    Google Scholar 

  16. Fu B, Lun X, Gong Y. Effects of the combined therapy of acupuncture with herbal drugs on male immune infertility—a clinical report of 50 cases. J Tradit Chin Med 2005;25:186–189.

    PubMed  Google Scholar 

  17. Erices A, Conget P, Rojas C, Minguell JJ. GP130 activation by soluble interleukin-6 receptor/interleukin-6 enhances osteoblastic differentiation of human bone marrow-derived mesenchymas stem cells. Exp Cell Res 2002;280:24–32.

    Article  PubMed  CAS  Google Scholar 

  18. Mihara M, Hashizume M, Yoshida H, Suzuki M, Shiina M. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin Sci 2012;122:143–159.

    Article  PubMed  CAS  Google Scholar 

  19. Fang J, Zhang YX, Ru XB, Wei XL. Effect of liuwei dihuang decoction, on the cytokine expression in splenocytes in AA rats. China J Chin Mater Med (Chin) 2001;26:128–131.

    CAS  Google Scholar 

  20. Gao D, Zheng LP, Lin JM, Lin W, Chen XZ, Song J, et al. Experimental study on effect of Liuwei Dihuang Pill on HSC from mouse marrow. J Chin Med Mater (Chin) 2008;31:251–254.

    Google Scholar 

  21. Elsaeidi F, Bemben MA, Zhao XF, Goldman D. Jak/Stat signaling stimulates zebrafish optic nerve regeneration and overcomes the inhibitory actions of Socs3 and Sfpq. J Neurosci 2014;34:2632–2644.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Senaldi G, Varnum BC, Sarmiento U, Starnes C, Lile J, Scully S, et al. Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family. Proc Natl Acad Sci U S A 1999;96:11458–11463.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Burger R, Bakker F, Guenther A, Baum W, Schmidt-Arras D, Hideshima T, et al. Functional significance of novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) for human myeloma cell growth and survival. Br J Haematol 2003;123:869–878.

    Article  PubMed  CAS  Google Scholar 

  24. Elson GC, Lelièvre E, Guillet C, Chevalier S, Plun-Favreau H, Froger J, et al. CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex. Nat Neurosci 2000;3:867–872.

    Article  PubMed  CAS  Google Scholar 

  25. Moortgat S, Benoit V, Deprez M, Charon A, Maystadt I. A new Turkish infant with clinical features of CS/CISS1 syndrome and homozygous CRLF1 mutation. Eur J Med Genet 2014;57:212–215.

    Article  PubMed  Google Scholar 

  26. Hahn AF, Waaler PE, Kvistad PH, Bamforth JS, Miles JH, McLeod JG, et al. Cold-induced sweating syndrome CISS1 and CISS2: manifestations from infancy to adulthood. Four new cases. J Neurol Sci 2010;293:68–75.

    PubMed  CAS  Google Scholar 

  27. Aljabari S, Howard E, Bell T, Vasylyeva TL. Cold induced sweating syndrome with urinary system anomaly association. Case Rep Pediatr 2013;2013:173890.

    PubMed  PubMed Central  Google Scholar 

  28. Coskun M, Salem M, Pedersen J, Nielsen OH. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease. Pharmacol Res 2013;76:1–8.

    Article  PubMed  CAS  Google Scholar 

  29. Joung YH, Lim EJ, Darvin P, Chung SC, Jang JW, Do Park K, et al. MSM enhances GH signaling via the Jak2/STAT5b pathway in osteoblast-like cells and osteoblast differentiation through the activation of STAT5b in MSCs. PLoS One 2012;7:e47477.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Huang E, Zhu G, Jiang W, Yang K, Gao Y, Luo Q, et al. Growth hormone synergizes with BMP9 in osteogenic differentiation by activating the JAK/STAT/IGF1 pathway in murine multilineage cells. J Bone Mineral Res 2012;27:1566–1575.

    Article  CAS  Google Scholar 

  31. Li CH, Zhao JX, Sun L, Yao ZQ, Deng XL, Liu R, et al. AG490 inhibits NFATc1 expression and STAT3 activation during RANKL induced osteoclastogenesis. Biochem Biophys Res Commun 2013;435:533–539.

    Article  PubMed  CAS  Google Scholar 

  32. Bellido T, Borba VZ, Roberson P, Manolagas SC. Activation of the Janus kinase/STAT (signal transducer and activator of transcription) signal transduction pathway by interleukin-6-type cytokines promotes osteoblast differentiation. Endocrinology 1997;138:3666–3676.

    Article  PubMed  CAS  Google Scholar 

  33. Nishimura R, Moriyama K, Yasukawa K, Mundy GR, Yoneda T. Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells. J Bone Miner Res 1998;13:777–785.

    Article  PubMed  CAS  Google Scholar 

  34. Tawara K, Oxford JT, Jorcyk CL. Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potentialofanti-IL-6 therapies. Cancer Manag Res 2011;3:177–189.

    PubMed  PubMed Central  CAS  Google Scholar 

  35. Itoh S, Udagawa N, Takahashi N, Yoshitake F, Narita H, Ebisu S, et al. A critical role for interleukin-6 familymediated Stat3 activation in osteoblast differentiation and bone formation. Bone 2006;39:505–512.

    Article  PubMed  CAS  Google Scholar 

  36. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003;374:1–20.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  37. Abraham AK, Ramanathan M, Weinstock-Guttman B, Mager DE. Mechanisms of interferon-beta effects on bone homeostasis. Biochem Pharmacol 2009;77:1757–1762.

    Article  PubMed  CAS  Google Scholar 

  38. Sun GJ, Guo T, Chen Y, Xu B, Guo JH, Zhao JN. Significant pathways detection in osteoporosis based on the bibliometric network. Eur Rev Med Pharmacol Sci 2013;17:1–7.

    PubMed  CAS  Google Scholar 

  39. Platanias CL, Fish EN. Signaling pathways activated by interferons. Exp Hematol 1999;27:1583–1592.

    Article  PubMed  CAS  Google Scholar 

  40. González-Navajas JM, Lee J, David M, Raz E. Immunomodulatory functions of type I interferons. Nat Rev Immunol 2012;12:125–135.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  41. Laroche M, Livideanu C, Paul C, Cantagrel A. Interferon alpha and pamidronate in osteoporosis with fracture secondary to mastocytosis. Am J Med 2011;124:776–778.

    Article  PubMed  CAS  Google Scholar 

  42. Kim S, Takayanagi H. The regulation of osteoclastogenesis by IFN. Nihon Rinsho 2005;63:1553–1561.

    PubMed  Google Scholar 

  43. de Bruin AM, Voermans C, Nolte MA. Impact of interferon-γ on hematopoiesis. Blood 2014;124:2479–2486.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Key Research Laboratory of Osteoporosis Syndrome Genomics, Fujian Academy of Traditional Chinese Medicine, Fuzhou, 350003, China

    Ji-rong Ge, Li-hua Xie, Juan Chen, Sheng-qiang Li, Hui-juan Xu, Yu-lian Lai, Long-long Qiu & Chen-bo Ni

Authors
  1. Ji-rong Ge
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Li-hua Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Juan Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sheng-qiang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hui-juan Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yu-lian Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Long-long Qiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chen-bo Ni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ji-rong Ge.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ge, Jr., Xie, Lh., Chen, J. et al. Liuwei Dihuang Pill (六味地黄丸) Treats Postmenopausal Osteoporosis with Shen (Kidney) Yin Deficiency via Janus Kinase/Signal Transducer and Activator of Transcription Signal Pathway by Up-regulating Cardiotrophin-Like Cytokine Factor 1 Expression. Chin. J. Integr. Med. 24, 415–422 (2018). https://doi.org/10.1007/s11655-016-2744-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-016-2744-2

Keywords

Search

Navigation